Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

BACKGROUND: Cellular therapy after organ transplantation is emerging as an intriguing strategy to achieve dose reduction of classical immunosuppressive pharmacotherapy. Here, we introduce a new scoring system to assess treatment-emergent adverse events (TEAEs) of adherent stem cell therapies in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillmann, Johannes, Popp, Felix C, Fillenberg, Barbara, Zeman, Florian, Eggenhofer, Elke, Farkas, Stefan, Scherer, Marcus N, Koller, Michael, Geissler, Edward K, Deans, Robert, Ladenheim, Deborah, Loss, Martin, Schlitt, Hans J, Dahlke, Marc H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543274/
https://www.ncbi.nlm.nih.gov/pubmed/23151227
http://dx.doi.org/10.1186/1745-6215-13-211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543274/
https://www.ncbi.nlm.nih.gov/pubmed/23151227
http://dx.doi.org/10.1186/1745-6215-13-211

Ejemplares similares